{"id":797359,"date":"2022-06-07T15:56:54","date_gmt":"2022-06-07T13:56:54","guid":{"rendered":"https:\/\/bebeez.it\/non-categorizzato\/versant-ventures-to-file-early-warning-report-in-respect-of-repare-therapeutics-inc\/"},"modified":"2023-07-11T10:44:06","modified_gmt":"2023-07-11T08:44:06","slug":"versant-ventures-to-file-early-warning-report-in-respect-of-repare-therapeutics-inc-2","status":"publish","type":"post","link":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-to-file-early-warning-report-in-respect-of-repare-therapeutics-inc-2\/","title":{"rendered":"Versant Ventures to File Early Warning Report in Respect of Repare Therapeutics Inc."},"content":{"rendered":"VANCOUVER, British Columbia & MONTREAL--(BUSINESS WIRE)--Versant Ventures today announced it will file an early warning report with respect to the ownership of securities in Repare Therapeutics Inc. (the \u201cCompany\u201d) by Versant Venture Capital VI, L.P., Versant Vantage I, L.P., Versant Venture Capital V, L.P., Versant Venture Capital V (Canada) LP, Versant Ophthalmic Affiliates Fund I, L.P. and Versant Affiliates Fund V, L.P. (collectively, the \u201cVersant Funds\u201d).\n\n\nOn June 6, 2022, some of the Versant Funds distributed an aggregate of 700,000 common shares in the capital of the Company (\u201cCommon Shares\u201d) pursuant to a discretionary distribution to their respective partners for no additional consideration. The 700,000 Common Shar
Abbonati<\/a> o Accedi<\/a> per leggere il resto di questo contenuto.<\/div><\/div>","protected":false},"excerpt":{"rendered":"

VANCOUVER, British Columbia & MONTREAL–(BUSINESS WIRE)–Versant Ventures today announced it will file an early warning report with respect to the ownership of securities in Repare Therapeutics Inc. (the \u201cCompany\u201d) by Versant Venture Capital VI, L.P., Versant Vantage I, L.P., Versant Venture Capital V, L.P., Versant Venture Capital V (Canada) LP, Versant Ophthalmic Affiliates Fund I, […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[49625],"tags":[],"settori":[],"slider_categorie_and_home_page":[],"class_list":["post-797359","post","type-post","status-publish","format-standard","hentry","category-private-capital-in-north-america"],"acf":[],"yoast_head":"\nVersant Ventures to File Early Warning Report in Respect of Repare Therapeutics Inc. - BeBeez<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-to-file-early-warning-report-in-respect-of-repare-therapeutics-inc-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Versant Ventures to File Early Warning Report in Respect of Repare Therapeutics Inc. - BeBeez\" \/>\n<meta property=\"og:description\" content=\"VANCOUVER, British Columbia & MONTREAL--(BUSINESS WIRE)--Versant Ventures today announced it will file an early warning report with respect to the ownership of securities in Repare Therapeutics Inc. (the \u201cCompany\u201d) by Versant Venture Capital VI, L.P., Versant Vantage I, L.P., Versant Venture Capital V, L.P., Versant Venture Capital V (Canada) LP, Versant Ophthalmic Affiliates Fund I, […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-to-file-early-warning-report-in-respect-of-repare-therapeutics-inc-2\/\" \/>\n<meta property=\"og:site_name\" content=\"BeBeez\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-07T13:56:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-11T08:44:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"683\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"olomaster\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"olomaster\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-to-file-early-warning-report-in-respect-of-repare-therapeutics-inc-2\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-to-file-early-warning-report-in-respect-of-repare-therapeutics-inc-2\/\"},\"author\":{\"name\":\"olomaster\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/person\/f3523ef027b0af56aa28725439cc9518\"},\"headline\":\"Versant Ventures to File Early Warning Report in Respect of Repare Therapeutics Inc.\",\"datePublished\":\"2022-06-07T13:56:54+00:00\",\"dateModified\":\"2023-07-11T08:44:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-to-file-early-warning-report-in-respect-of-repare-therapeutics-inc-2\/\"},\"wordCount\":561,\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"articleSection\":[\"Private capital in North America\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-to-file-early-warning-report-in-respect-of-repare-therapeutics-inc-2\/\",\"url\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-to-file-early-warning-report-in-respect-of-repare-therapeutics-inc-2\/\",\"name\":\"Versant Ventures to File Early Warning Report in Respect of Repare Therapeutics Inc. - BeBeez\",\"isPartOf\":{\"@id\":\"https:\/\/15.161.165.86\/#website\"},\"datePublished\":\"2022-06-07T13:56:54+00:00\",\"dateModified\":\"2023-07-11T08:44:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-to-file-early-warning-report-in-respect-of-repare-therapeutics-inc-2\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-to-file-early-warning-report-in-respect-of-repare-therapeutics-inc-2\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-to-file-early-warning-report-in-respect-of-repare-therapeutics-inc-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bebeez.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Versant Ventures to File Early Warning Report in Respect of Repare Therapeutics Inc.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/15.161.165.86\/#website\",\"url\":\"https:\/\/15.161.165.86\/\",\"name\":\"BeBeez\",\"description\":\"BeBeez\",\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/15.161.165.86\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/15.161.165.86\/#organization\",\"name\":\"BeBeez\",\"url\":\"https:\/\/15.161.165.86\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"contentUrl\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"width\":309,\"height\":122,\"caption\":\"BeBeez\"},\"image\":{\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/person\/f3523ef027b0af56aa28725439cc9518\",\"name\":\"olomaster\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f27d32333d7dec7da2843c6d51349029304daff2c6c3fb07164f8de234678661?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f27d32333d7dec7da2843c6d51349029304daff2c6c3fb07164f8de234678661?s=96&d=mm&r=g\",\"caption\":\"olomaster\"},\"url\":\"https:\/\/bebeez.it\/en\/author\/olomaster\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Versant Ventures to File Early Warning Report in Respect of Repare Therapeutics Inc. - BeBeez","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-to-file-early-warning-report-in-respect-of-repare-therapeutics-inc-2\/","og_locale":"en_US","og_type":"article","og_title":"Versant Ventures to File Early Warning Report in Respect of Repare Therapeutics Inc. - BeBeez","og_description":"VANCOUVER, British Columbia & MONTREAL--(BUSINESS WIRE)--Versant Ventures today announced it will file an early warning report with respect to the ownership of securities in Repare Therapeutics Inc. (the \u201cCompany\u201d) by Versant Venture Capital VI, L.P., Versant Vantage I, L.P., Versant Venture Capital V, L.P., Versant Venture Capital V (Canada) LP, Versant Ophthalmic Affiliates Fund I, […]","og_url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-to-file-early-warning-report-in-respect-of-repare-therapeutics-inc-2\/","og_site_name":"BeBeez","article_published_time":"2022-06-07T13:56:54+00:00","article_modified_time":"2023-07-11T08:44:06+00:00","og_image":[{"width":683,"height":242,"url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png","type":"image\/png"}],"author":"olomaster","twitter_card":"summary_large_image","twitter_misc":{"Written by":"olomaster","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-to-file-early-warning-report-in-respect-of-repare-therapeutics-inc-2\/#article","isPartOf":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-to-file-early-warning-report-in-respect-of-repare-therapeutics-inc-2\/"},"author":{"name":"olomaster","@id":"https:\/\/15.161.165.86\/#\/schema\/person\/f3523ef027b0af56aa28725439cc9518"},"headline":"Versant Ventures to File Early Warning Report in Respect of Repare Therapeutics Inc.","datePublished":"2022-06-07T13:56:54+00:00","dateModified":"2023-07-11T08:44:06+00:00","mainEntityOfPage":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-to-file-early-warning-report-in-respect-of-repare-therapeutics-inc-2\/"},"wordCount":561,"publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"articleSection":["Private capital in North America"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-to-file-early-warning-report-in-respect-of-repare-therapeutics-inc-2\/","url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-to-file-early-warning-report-in-respect-of-repare-therapeutics-inc-2\/","name":"Versant Ventures to File Early Warning Report in Respect of Repare Therapeutics Inc. - BeBeez","isPartOf":{"@id":"https:\/\/15.161.165.86\/#website"},"datePublished":"2022-06-07T13:56:54+00:00","dateModified":"2023-07-11T08:44:06+00:00","breadcrumb":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-to-file-early-warning-report-in-respect-of-repare-therapeutics-inc-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-to-file-early-warning-report-in-respect-of-repare-therapeutics-inc-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-to-file-early-warning-report-in-respect-of-repare-therapeutics-inc-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bebeez.it\/en\/"},{"@type":"ListItem","position":2,"name":"Versant Ventures to File Early Warning Report in Respect of Repare Therapeutics Inc."}]},{"@type":"WebSite","@id":"https:\/\/15.161.165.86\/#website","url":"https:\/\/15.161.165.86\/","name":"BeBeez","description":"BeBeez","publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/15.161.165.86\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/15.161.165.86\/#organization","name":"BeBeez","url":"https:\/\/15.161.165.86\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/","url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","contentUrl":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","width":309,"height":122,"caption":"BeBeez"},"image":{"@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/15.161.165.86\/#\/schema\/person\/f3523ef027b0af56aa28725439cc9518","name":"olomaster","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/15.161.165.86\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f27d32333d7dec7da2843c6d51349029304daff2c6c3fb07164f8de234678661?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f27d32333d7dec7da2843c6d51349029304daff2c6c3fb07164f8de234678661?s=96&d=mm&r=g","caption":"olomaster"},"url":"https:\/\/bebeez.it\/en\/author\/olomaster\/"}]}},"_links":{"self":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/797359","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/comments?post=797359"}],"version-history":[{"count":1,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/797359\/revisions"}],"predecessor-version":[{"id":891731,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/797359\/revisions\/891731"}],"wp:attachment":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/media?parent=797359"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/categories?post=797359"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/tags?post=797359"},{"taxonomy":"settori","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/settori?post=797359"},{"taxonomy":"slider_categorie_and_home_page","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/slider_categorie_and_home_page?post=797359"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}